Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Caitlin E. Cox

December 09, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Conference News AHA 2022

New Tool Assesses Risk in Acute HF Then Suggests Next Steps, Cutting Later Events

Yael L. Maxwell

November 07, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

Presentation TCT 2022

Keynote Lecture: TEER in Acute Decompensated Heart Failure: Indications, Technical Considerations and Outcomes

Presenter: David Rizik

September 18, 2022

Presentation TCT 2022

TCT 341: Intermittent Occlusion of the Superior Vena Cava Reduces Estimated Stressed Blood Volume in Patients with Acutely Decompensated Heart Failure

Presenter: Michael Kiernan

September 18, 2022

Presentation TCT 2022

TCT 340: Intermittent Occlusion of the Superior Vena Cava Improves Urine Sodium Excretion in Patients with Acutely Decompensated Heart Failure

Presenter: Rayan Yousefzai

September 18, 2022

Presentation TCT 2022

Expansion of TEER Indications: Acute Decompensated Heart Failure and Cardiogenic Shock

Presenter: Nicolas Van Mieghem

September 17, 2022

Presentation TCT 2022

Cardiac Pulmonary Nerve Stimulation for the Treatment of Acute Decompensated Heart Failure (Cardionomic)

Presenter: William Abraham

September 17, 2022

News Conference News ESC 2022

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

L.A. McKeown

August 27, 2022

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Daily News

US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution?

Shelley Wood

July 15, 2022

Presentation TVT 2022

A CLINICAL TEASER: Indications and Clinical Outcomes of TEER in Acute Decompensated Heart Failure

Presenter: Gilbert Tang

June 10, 2022

Presentation TVT 2022

CLIP-PRESSOR: Mitral TEER in Acute Decompensated Heart Failure

Presenter: Arka Chatterjee

June 08, 2022

News Conference News ESC Heart Failure 2022

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

Shelley Wood

May 26, 2022

News Conference News ESC Heart Failure 2022

Speech-Recognition Tool May Predict Worsening Congestion in HF

Shelley Wood

May 22, 2022

News Conference News ACC 2022

QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis

L.A. McKeown

April 07, 2022

News Conference News THT 2022

Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality

Caitlin E. Cox

February 07, 2022

Presentation THT 2022

scPharma

Presenter: Daniel Bensimhon

February 01, 2022

Presentation THT 2022

WhiteSwell

Presenter: Sitaramesh Emani

February 01, 2022

Advertisement

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

New Tool Assesses Risk in Acute HF Then Suggests Next Steps, Cutting Later Events

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Keynote Lecture: TEER in Acute Decompensated Heart Failure: Indications, Technical Considerations and Outcomes

TCT 341: Intermittent Occlusion of the Superior Vena Cava Reduces Estimated Stressed Blood Volume in Patients with Acutely Decompensated Heart Failure

TCT 340: Intermittent Occlusion of the Superior Vena Cava Improves Urine Sodium Excretion in Patients with Acutely Decompensated Heart Failure

Expansion of TEER Indications: Acute Decompensated Heart Failure and Cardiogenic Shock

Cardiac Pulmonary Nerve Stimulation for the Treatment of Acute Decompensated Heart Failure (Cardionomic)

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution?

A CLINICAL TEASER: Indications and Clinical Outcomes of TEER in Acute Decompensated Heart Failure

CLIP-PRESSOR: Mitral TEER in Acute Decompensated Heart Failure

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

Speech-Recognition Tool May Predict Worsening Congestion in HF

QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis

Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality

scPharma

WhiteSwell

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content